Opportunity Information: Apply for W81XWH 16 PCRP IDA
Apply for W81XWH 16 PCRP IDA
- The DOD-AMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Prostate Cancer Idea Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on May 05, 2016 and posted on May 05, 2016.
- Applicants must submit their applications by Oct 06, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 34 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) is a long-running funding mechanism designed to back genuinely new, high-impact concepts in prostate cancer research. First offered in FY97, it has attracted a large national response over time (9,087 applications received, with 1,161 recommended for funding), which signals both strong competition and a clear track record of supporting projects that reviewers see as meaningful and field-shifting. The central purpose of the award is to accelerate innovative ideas that can make an important contribution to the PCRP mission, rather than to support routine, incremental extensions of already-published work.
A defining feature of this opportunity is its emphasis on innovation with a reasonable, defensible scientific foundation. The program explicitly accepts that breakthrough research can involve risk, but it expects applicants to show that the idea is grounded in sound rationale built from logical reasoning and/or careful analysis of existing literature. Preliminary data are encouraged because they can strengthen feasibility and credibility, but they are not required, which lowers the barrier for testing bolder hypotheses or unconventional approaches. If applicants do include unpublished preliminary results, those data are expected to come from the Principal Investigator (PI) or members of the research team, reinforcing accountability and authenticity. The PCRP draws a sharp line between innovation and incremental progress: proposals that simply advance published work in small steps are not considered innovative, while proposals that introduce a new paradigm, challenge existing assumptions, reframe established problems, or display highly creative approaches are aligned with the award’s intent.
The IDA is intentionally broad in the kinds of investigators and disciplines it wants to attract. The solicitation welcomes proposals across basic science, engineering, bioinformatics, population science, psycho-oncology, translational research, and clinical research, among others. Regardless of discipline, applicants are expected to align the project with at least one PCRP focus area and are strongly encouraged to address one of the PCRP overarching challenges. If a project does not directly map to an overarching challenge, the application needs to make a clear case that it still addresses a critical unmet need in prostate cancer research and/or patient care. In other words, alignment is important, but the program leaves room for compelling ideas that solve urgent problems even if they do not fit neatly into the headline challenge categories.
Impact is weighted heavily, both in the near term and longer term, with an expectation that the work could meaningfully change scientific understanding, research direction, or clinical practice related to prostate cancer. To improve the credibility and downstream usefulness of funded research, the opportunity encourages applicants to build strong study design practices into their proposals where appropriate. Examples specifically highlighted include cell line authentication, statistical rigor in preclinical animal studies, and experiments that directly test clinical relevance and translatability. The program also points applicants toward established resources that can strengthen human relevance, including the PCRP-funded Prostate Cancer Biorepository Network (PCBN) and the North Carolina-Louisiana Prostate Cancer Project (PCaP), particularly when retrospectively collected human biospecimens or linked clinical and demographic data are essential to the research question. Consistent with modern data-driven research, the announcement also encourages studies that leverage large patient datasets with long-term health records and biospecimen repositories, especially when paired with state-of-the-art genomics/proteomics, bioinformatics, and mathematical modeling.
The award includes structural features aimed at supporting both early-career independence and high-powered collaborations. A dedicated New Investigator category is meant to give early-stage faculty or investigators building independent careers a fairer competitive lane separate from established investigators. New Investigators are strongly encouraged to collaborate with experienced prostate cancer researchers or other domain experts, and they must explicitly explain how those partnerships fill gaps in expertise and improve the project’s chances of success. Importantly, New Investigators are not eligible for the Partnering PI Option, which is reserved for established investigators.
For more senior teams, the Partnering PI Option provides a higher funding level to support truly synergistic, multi-PI research efforts. This structure can include up to three PIs, with one serving as the Initiating PI who leads most administrative responsibilities, and the others serving as Partnering PIs. Each PI is expected to play a substantial role in shaping and executing the work, and if the project is funded, each PI receives a separate award. The application must clearly justify why the collaboration is necessary by describing the unique expertise each PI brings and the specific synergistic components that make the work faster or better than independent projects could achieve. Multidisciplinary and multi-institutional projects are allowed and encouraged, especially those incorporating population science, but they come with added expectations: the proposal must include a clear interaction plan covering communication, coordination of progress and results, and data transfer. Multi-institutional teams must also provide an intellectual property plan to prevent IP or material transfer issues from undermining cooperation or slowing the research.
From an administrative standpoint, this opportunity (Funding Opportunity Number W81XWH 16 PCRP IDA) was issued by DOD-AMRAA under CFDA 12.420 and allows for funding through grants and cooperative agreements. Eligibility is described as unrestricted (open to any entity type, subject to any clarifications in the full announcement). The posting date was May 5, 2016, with an application closing date of October 6, 2016, and an expected 34 awards indicated in the source listing.
FAQs: DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA)
What is the PCRP Idea Development Award (IDA)?
The DoD Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) is a long-running funding mechanism intended to support genuinely new, high-impact concepts in prostate cancer research. It focuses on accelerating innovative ideas that can make an important contribution to the PCRP mission, rather than funding routine, incremental extensions of already-published work.
Who issues this funding opportunity?
This opportunity was issued by DOD-AMRAA (U.S. Department of Defense). The source listing also references CFDA 12.420.
What is the Funding Opportunity Number (FON) for this program?
The Funding Opportunity Number is W81XWH 16 PCRP IDA.
When was this opportunity posted and when did it close?
The posting date was May 5, 2016, and the application closing date was October 6, 2016.
How many awards were expected to be made?
The source listing indicates an expected 34 awards.
What types of funding instruments are used?
Funding is allowed through grants and cooperative agreements.
How competitive is the IDA program?
The program has attracted a large national response over time. Since first being offered in FY97, it received 9,087 applications, with 1,161 recommended for funding. This suggests strong competition and a demonstrated track record of supporting projects reviewers view as meaningful and field-shifting.
What is the main goal of the IDA?
The central purpose is to accelerate innovative ideas that can make an important contribution to the PCRP mission. The program is designed to support research that introduces a new paradigm, challenges existing assumptions, reframes established problems, or uses highly creative approaches, rather than small-step advances of published work.
What does the program mean by "innovation"?
Innovation is described as work that goes beyond incremental progress. The solicitation draws a clear distinction: proposals that simply advance published work in small steps are not considered innovative, while proposals that introduce a new paradigm, challenge assumptions, reframe problems, or use highly creative approaches are aligned with the award intent.
Is high-risk research allowed?
Yes. The program explicitly accepts that breakthrough research can involve risk, but it expects a reasonable, defensible scientific foundation. Applicants are expected to show the idea is grounded in sound rationale built from logical reasoning and/or careful analysis of existing literature.
Are preliminary data required?
No. Preliminary data are encouraged because they can strengthen feasibility and credibility, but they are not required, which lowers the barrier for testing bolder hypotheses or unconventional approaches.
If preliminary data are included, where must they come from?
If unpublished preliminary results are included, they are expected to come from the Principal Investigator (PI) or members of the research team.
What research areas and disciplines are eligible?
The IDA is broad and welcomes proposals across many areas, including basic science, engineering, bioinformatics, population science, psycho-oncology, translational research, and clinical research, among others.
Do projects need to align with specific PCRP priorities?
Yes. Applicants are expected to align the project with at least one PCRP focus area and are strongly encouraged to address one of the PCRP overarching challenges.
What if a project does not directly map to an overarching challenge?
If a project does not directly map to an overarching challenge, the application needs to make a clear case that it still addresses a critical unmet need in prostate cancer research and/or patient care.
How important is "impact" in the review expectations?
Impact is weighted heavily in both the near term and longer term. The expectation is that the work could meaningfully change scientific understanding, research direction, or clinical practice related to prostate cancer.
What study design practices are encouraged?
To strengthen credibility and downstream usefulness, the opportunity encourages strong study design practices where appropriate. Examples specifically highlighted include cell line authentication, statistical rigor in preclinical animal studies, and experiments that directly test clinical relevance and translatability.
Are there specific resources the program encourages applicants to use?
Yes. The opportunity points to established resources that can strengthen human relevance, including the PCRP-funded Prostate Cancer Biorepository Network (PCBN) and the North Carolina-Louisiana Prostate Cancer Project (PCaP), particularly when retrospectively collected human biospecimens or linked clinical and demographic data are essential to the research question.
Does the IDA encourage use of large patient datasets and advanced analytics?
Yes. The announcement encourages studies leveraging large patient datasets with long-term health records and biospecimen repositories, especially when paired with state-of-the-art genomics/proteomics, bioinformatics, and mathematical modeling.
What is the New Investigator category?
The IDA includes a dedicated New Investigator category intended to provide a fairer competitive lane for early-stage faculty or investigators who are building independent careers, separate from established investigators.
Are New Investigators encouraged to collaborate?
Yes. New Investigators are strongly encouraged to collaborate with experienced prostate cancer researchers or other domain experts. They must explicitly explain how those partnerships fill gaps in expertise and improve the project’s chances of success.
Can New Investigators use the Partnering PI Option?
No. New Investigators are not eligible for the Partnering PI Option, which is reserved for established investigators.
What is the Partnering PI Option?
The Partnering PI Option is a structure for senior or established teams that provides a higher funding level to support truly synergistic, multi-PI research efforts.
How many PIs can be included under the Partnering PI Option?
The structure can include up to three PIs. One PI serves as the Initiating PI (with most administrative responsibilities), and the others serve as Partnering PIs.
If funded, how are awards handled for multiple PIs?
If the project is funded, each PI receives a separate award.
What must the application show to justify a Partnering PI collaboration?
The application must clearly justify why the collaboration is necessary by describing the unique expertise each PI brings and the specific synergistic components that make the work faster or better than independent projects could achieve.
Are multidisciplinary and multi-institutional projects allowed?
Yes. Multidisciplinary and multi-institutional projects are allowed and encouraged, including those incorporating population science.
What additional expectations apply to multidisciplinary or multi-institutional teams?
The proposal must include a clear interaction plan covering communication, coordination of progress and results, and data transfer. Multi-institutional teams must also provide an intellectual property (IP) plan to prevent IP or material transfer issues from undermining cooperation or slowing the research.
What does eligibility "unrestricted" mean here?
Eligibility is described as unrestricted (open to any entity type), subject to any clarifications in the full announcement.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Procurement Technical Assistance Program
Previous opportunity: Complete Channel Islands National Park Administrative History
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 16 PCRP IDA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 16 PCRP IDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Prostate Cancer Health Disparity Research Award Apply for W81XWH 16 PCRP HDRA Funding Number: W81XWH 16 PCRP HDRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Prediction of and Resilience against Extreme Events Apply for 16 562 Funding Number: 16 562 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Accelerated Computation for Efficient Scientific Simulation (ACCESS) Apply for DARPA BAA 16 38 Funding Number: DARPA BAA 16 38 Agency: DOD-DARPA-DSO Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY 17 Communications and Networking Discovery and Invention Apply for N00014 16 S BA11 Funding Number: N00014 16 S BA11 Agency: DOD-ONR Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis Clinical Consortium Award Apply for W81XWH 16 NFRP CCA Funding Number: W81XWH 16 NFRP CCA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Curatorial Stewardship of a National Collection of Geological Rock & Sediment Cores from Antarctica and the Southern Ocean Apply for 16 563 Funding Number: 16 563 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $350,000 |
| DoD Tuberous Sclerosis Complex Exploration-Hypothesis Development Award Apply for W81XWH 16 TSCRP EHDA Funding Number: W81XWH 16 TSCRP EHDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Tuberous Sclerosis Idea Development Award Apply for W81XWH 16 TSCRP IDA Funding Number: W81XWH 16 TSCRP IDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis New Investigator Award Apply for W81XWH 16 NFRP NIA Funding Number: W81XWH 16 NFRP NIA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY16 Tuberous Sclerosis Complex Pilot Clinical Trial Award Apply for W81XWH 16 TSCRP PCTA Funding Number: W81XWH 16 TSCRP PCTA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Conservation of Civil War Parrott Rifles, Carriages and Chassisâ¿¿ Apply for P16AS00153 Funding Number: P16AS00153 Agency: DOI-NPS Category: Science and Technology and other Research and Development Funding Amount: $93,588 |
| FY16 Tuberous Sclerosis Complex Synergistic Idea Development Award Apply for W81XWH 16 TSCRP SIDA Funding Number: W81XWH 16 TSCRP SIDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis Investigator-Initiated Research Award Apply for W81XWH 16 NFRP IIRA Funding Number: W81XWH 16 NFRP IIRA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Neurofibromatosis Clinical Trial Award Apply for W81XWH 16 NFRP CTA Funding Number: W81XWH 16 NFRP CTA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Tuberous Sclerosis Complex Postdoctoral Development Award Apply for W81XWH 16 TSCRP PDA Funding Number: W81XWH 16 TSCRP PDA Agency: DOD-AMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| NSF/DOE Partnership in Basic Plasma Science and Engineering Apply for 16 564 Funding Number: 16 564 Agency: NSF Category: Science and Technology and other Research and Development Funding Amount: $250,000 |
| Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development Apply for 2016 NIST NICE 01 Funding Number: 2016 NIST NICE 01 Agency: DOC-NIST Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Enhance the Ability of Emergency Medical Services (EMS) to transport patients with highly infectious diseases (HID) Apply for EP IDS 16 003 Funding Number: EP IDS 16 003 Agency: HHS-OS-ASPR Category: Science and Technology and other Research and Development Funding Amount: $350,000 |
| TRADES Apply for DARPA BAA 16 39 Funding Number: DARPA BAA 16 39 Agency: DOD-DARPA-DSO Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Small Business Innovation Research Program (SBIR) Phase II 93.433 HHS/ACL/NIDILRR Apply for HHS 2016 ACL NIDILRR BISB 0182 Funding Number: HHS 2016 ACL NIDILRR BISB 0182 Agency: HHS-ACL Category: Science and Technology and other Research and Development Funding Amount: $575,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 16 PCRP IDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
